Condition
Ovarian Hyper Stimulation Syndrome (OHSS)
Total Trials
3
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Recruiting1
Completed1
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07568886Not ApplicableCompletedPrimary
Albumin and Furosemide for Preventing Ovarian Hyperstimulation Syndrome in ICSI Patients
NCT06739759Not ApplicableRecruitingPrimary
Ovarian Hyperstimulation Syndrome Prevention
NCT01843569Not ApplicableWithdrawn
In Vitro Maturation (IVM) of Human Oocytes
Showing all 3 trials